Viamet Pharmaceuticals Appoints Former Novartis Executive Marc Rudoltz, M.D. as Chief Medical Officer

Viamet Pharmaceuticals has named Novartis Oncology industry veteran Dr. Marc Rudoltz as its new Chief Medical Officer.... [more]

View complete Press Release article